Foundry Partners’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-282,268
| Closed | -$2.09M | – | 347 |
|
|
2022
Q4 | $2.09M | Buy |
+282,268
| New | +$2.09M | 0.12% | 193 |
|
|
2020
Q1 | – | Sell |
-45,507
| Closed | -$747K | – | 420 |
|
|
2019
Q4 | $747K | Sell |
45,507
-1,116
| -2% | -$18.3K | 0.03% | 330 |
|
|
2019
Q3 | $619K | Sell |
46,623
-110
| -0.2% | -$1.46K | 0.03% | 330 |
|
|
2019
Q2 | $658K | Sell |
46,733
-144
| -0.3% | -$2.03K | 0.03% | 332 |
|
|
2019
Q1 | $863K | Sell |
46,877
-3,220
| -6% | -$59.3K | 0.03% | 325 |
|
|
2018
Q4 | $1.31M | Sell |
50,097
-85
| -0.2% | -$2.22K | 0.06% | 301 |
|
|
2018
Q3 | $1.15M | Sell |
50,182
-78
| -0.2% | -$1.79K | 0.04% | 321 |
|
|
2018
Q2 | $957K | Sell |
50,260
-3,270
| -6% | -$62.3K | 0.04% | 316 |
|
|
2018
Q1 | $902K | Sell |
53,530
-23,630
| -31% | -$398K | 0.04% | 332 |
|
|
2017
Q4 | $1.17M | Sell |
77,160
-61,286
| -44% | -$932K | 0.05% | 306 |
|
|
2017
Q3 | $2.48M | Buy |
+138,446
| New | +$2.48M | 0.1% | 289 |
|